From the Food and Drug Administration: Ways to Reduce Risk of Highly Pathogenic Avian Influenza in Cats
Food and Drug Administration (FDA) Outlines Ways to Reduce Risk of Highly Pathogenic Avian Influenza (HPAI) in Cats
January 17, 2025

The U.S. Food and Drug Administration is providing pet owners and animal caretakers with information about ways to reduce the risk to their animals of contracting Highly Pathogenic Avian Influenza (HPAI or H5N1).
Felines, including both domestic and wild cats, such as tigers, mountain lions, lynx, etc., are particularly sensitive to H5N1 and care should be taken to not expose these animals to the virus. Dogs can also contract HPAI, although they usually exhibit mild clinical signs and low mortality compared to cats. At present, HPAI has not been detected in dogs in the United States, but there have been fatal cases in other countries.